Vaccine efficacy against the SARS-CoV-2 Delta variant during a COVID-19 outbreak aboard a military ship
BMJ Mil Health
.
2024 Jan 25;170(1):91-92.
doi: 10.1136/bmjmilitary-2022-002082.
Authors
Nancy Maugey
1
,
T Lefebvre
2
,
J-N Tournier
3
,
F Neulat-Ripoll
3
,
C Chapus
3
,
V Grandperret
3
,
F Raynaud
4
,
F Letois
1
,
F Dutasta
5
,
F Janvier
5
,
A Wolf
6
,
F de Laval
7
8
Affiliations
1
French Armed Forces Center for Epidemiology and Public Health, Marseille, France.
2
SSA (French Military Health Service), Toulon, France.
3
French Armed Forces Biomedical Research Institute, Brétigny-sur-Orge, France.
4
CBRN Management, French Defense Procurement Agency (DGA), Vert-le-Petit, France.
5
Sainte Anne Military Teaching Hospital, Toulon, France.
6
Bégin Military Teaching Hospital, Saint-Mandé, France.
7
French Armed Forces Center for Epidemiology and Public Health, Marseille, France
[email protected]
.
8
Aix-Marseille University, INSERM, IRD, SESSTIM (Economic and Social Sciences, Health Systems, and Medical Informatics), Marseille, France.
PMID:
35487589
DOI:
10.1136/bmjmilitary-2022-002082
No abstract available
Keywords:
COVID-19; EPIDEMIOLOGY; Public health.
Publication types
Letter
MeSH terms
COVID-19* / prevention & control
Humans
Military Personnel*
SARS-CoV-2
Ships
Vaccine Efficacy
Supplementary concepts
SARS-CoV-2 variants